Top of this page
Skip navigation, go straight to the content

Newsroom Press Releases

Search Press releases


Disposals of own shares20 Nov 2020

Disposals of own shares

Read more
UCB’s VIMPAT[®] (lacosamide) CV now approved by FDA in U.S. for primary generalized tonic-clonic seizures and expanded pediatric use for people living with epilepsy17 Nov 2020

UCB’s VIMPAT[®] (lacosamide) CV now approved by FDA in …

Read more
UCB strengthens its gene therapy activities with additional pipeline programs, capabilities and platforms12 Nov 2020

UCB strengthens its gene therapy activities with additional pipeline programs …

Read more
Disposals of own shares10 Nov 2020

Disposals of own shares

Read more
UCB Showcases Key Rheumatology Data at American College of Rheumatology Convergence 202006 Nov 2020

UCB Showcases Key Rheumatology Data at American College of Rheumatology …

Read more
Bimekizumab Phase 3 Data Shows Superior Skin Clearance Over Humira[®] in Moderate-to-Severe Psoriasis Patients31 Oct 2020

Bimekizumab Phase 3 Data Shows Superior Skin Clearance Over Humira …

Read more


Stay up-to-date on the latest news and information from UCB